The pivotal role of IL-2 in setting the size of the peripheral Treg compartment has led to therapeutic IL-2 administration being tested in mouse models of autoimmunity 52,98,99 and subsequently in several human clinical trials 100–103. Here, IL2 is linked to Autoimmunity.